Phio Pharmaceuticals Financials - Benzinga

Phio Pharmaceuticals Corp

PHIONASDAQ

Trade with Public

Trade with Public

$1.04

-0.02-1.89%

At close: Aug 6, 5:00 PM EST

$1.05

-0.01-0.94%

Pre-Market: 5:31 AM EST

Earnings: Q2 2026 Earnings were released on Thu Aug 6th, after the market close

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Stock Report

Phio Pharmaceuticals Financials

Phio Pharmaceuticals (PHIO) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Phio Pharma Q1 EPS $(0.34) Misses $(0.23) Estimate

Phio Pharma (NASDAQ:PHIO) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.23) by 47.83 percent. This is a 27.66 percent increase over losses of $(0.47) per share from the

Benzinga Newsdesk

PRO
Phio Pharma Q4 EPS $(0.15) Beats $(0.41) Estimate

Benzinga Newsdesk

PRO
Phio Pharma Q3 EPS $(0.44) Misses $(0.40) Estimate

Phio Pharma (NASDAQ:PHIO) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.40) by 10 percent. This is a 71.43 percent increase over losses of $(1.54) per share from the

Benzinga Newsdesk

PRO
Phio Pharma Q2 EPS $(0.45) Misses $(0.36) Estimate

Phio Pharma (NASDAQ:PHIO) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of $(0.36) by 25 percent. This is a 87.57 percent increase over losses of $(3.62) per share from the

Benzinga Newsdesk

PRO
Phio Pharma Q1 EPS $(0.47) Down From $(0.41) YoY

Phio Pharma (NASDAQ:PHIO) reported quarterly losses of $(0.47) per share. This is a 14.63 percent decrease over losses of $(0.41) per share from the same period last year.

Benzinga Newsdesk

Crude Oil Down 4%; Neogen Shares Plunge After Q3 Results

Avi Kapoor